SCHEMBL19909532

SCHEMBL19909532

Cc1cc(-c2cc(-n3c4cc(C(C)(C)C)ccc4c4ccc(C(C)(C)C)cc43)c(-n3c4cc(C(C)(C)C)ccc4c4ccc(C(C)(C)C)cc43)cc2C#N)cc(C)n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.32
NPSR1 Q6W5P4 3/20 0.32
KDM4E B2RXH2 3/20 0.32
CSNK1D P48730 1/20 0.32
CSNK1G2 P78368 1/20 0.32
KIF11 P52732 1/20 0.31
HPGD P15428 4/20 0.30
MAPT P10636 2/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HTT P42858 2/20 0.30
CYP1A2 P05177 2/20 0.30
CYP2C19 P33261 2/20 0.30
CYP2C9 P11712 1/20 0.30
LMNA P02545 1/20 0.30
CYP3A4 P08684 1/20 0.30
TSHR P16473 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
GRM2 Q14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909531 0.94 NPSR1 (0.32) ALDH1A1NPSR1KDM4EKIF11HPGD
SCHEMBL19913218 0.92 CSNK1D (0.33) ALDH1A1NPSR1KDM4ECSNK1DCSNK1G2
SCHEMBL19919792 0.89 TSHR (0.38) KIF11SMN1; SMN2TSHRGRM2
SCHEMBL22563601 0.88 CSNK1D (0.32) ALDH1A1NPSR1KDM4ECSNK1DCSNK1G2
SCHEMBL19909170 0.88 NPSR1 (0.32) ALDH1A1NPSR1KDM4ECSNK1DCSNK1G2
SCHEMBL23299815 0.86 SCN9A (0.32) KIF11
SCHEMBL19908974 0.86 METAP2 (0.38) ALDH1A1NPSR1KDM4EKIF11HPGD
SCHEMBL19909071 0.85 TSHR (0.36) KIF11SMN1; SMN2TSHRGRM2
SCHEMBL21278733 0.85 ALDH1A1 (0.32) ALDH1A1NPSR1CSNK1DCSNK1G2HPGD
SCHEMBL19909139 0.85 MAOA (0.34) ALDH1A1NPSR1KDM4EHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 ALDH1A1 297/4885NPSR1 876/4885KDM4E 4526/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 ALDH1A1 297/4885NPSR1 876/4885KDM4E 4526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.